Product Details for ANDA 040903
IMIPRAMINE HYDROCHLORIDE (IMIPRAMINE HYDROCHLORIDE)
10MG
Marketing Status: Prescription
25MG
Marketing Status: Prescription
50MG
Marketing Status: Prescription
10MG
Marketing Status: Prescription
Active Ingredient: IMIPRAMINE HYDROCHLORIDE
Proprietary Name: IMIPRAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040903
Product Number: 001
Approval Date: Oct 24, 2012
Applicant Holder Full Name: LEADING PHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
IMIPRAMINE HYDROCHLORIDE (IMIPRAMINE HYDROCHLORIDE)
Proprietary Name: IMIPRAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040903
Product Number: 001
Approval Date: Oct 24, 2012
Applicant Holder Full Name: LEADING PHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
25MG
Marketing Status: Prescription
Active Ingredient: IMIPRAMINE HYDROCHLORIDE
Proprietary Name: IMIPRAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040903
Product Number: 002
Approval Date: Oct 24, 2012
Applicant Holder Full Name: LEADING PHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
IMIPRAMINE HYDROCHLORIDE (IMIPRAMINE HYDROCHLORIDE)
Proprietary Name: IMIPRAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A040903
Product Number: 002
Approval Date: Oct 24, 2012
Applicant Holder Full Name: LEADING PHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
50MG
Marketing Status: Prescription
Active Ingredient: IMIPRAMINE HYDROCHLORIDE
Proprietary Name: IMIPRAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB
Application Number: A040903
Product Number: 003
Approval Date: Oct 24, 2012
Applicant Holder Full Name: LEADING PHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: IMIPRAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB
Application Number: A040903
Product Number: 003
Approval Date: Oct 24, 2012
Applicant Holder Full Name: LEADING PHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information